These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6822833

  • 1. Presynaptic cholinergic dysfunction in patients with dementia.
    Sims NR, Bowen DM, Allen SJ, Smith CC, Neary D, Thomas DJ, Davison AN.
    J Neurochem; 1983 Feb; 40(2):503-9. PubMed ID: 6822833
    [Abstract] [Full Text] [Related]

  • 2. Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease.
    Sims NR, Bowen DM, Smith CC, Flack RH, Davison AN, Snowden JS, Neary D.
    Lancet; 1980 Feb 16; 1(8164):333-6. PubMed ID: 6101790
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Do raised brain aluminium levels in Alzheimer's dementia contribute to cholinergic neuronal deficits?
    King RG.
    Med Hypotheses; 1984 Jul 16; 14(3):301-6. PubMed ID: 6472159
    [Abstract] [Full Text] [Related]

  • 5. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.
    Mouton PR, Meyer EM, Dunn AJ, Millard W, Arendash GW.
    Brain Res; 1988 Mar 15; 444(1):104-18. PubMed ID: 3359282
    [Abstract] [Full Text] [Related]

  • 6. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.
    Bowen DM, Benton JS, Spillane JA, Smith CC, Allen SJ.
    J Neurol Sci; 1982 Dec 15; 57(2-3):191-202. PubMed ID: 7161618
    [Abstract] [Full Text] [Related]

  • 7. Nicotinic acetylcholine binding sites in Alzheimer's disease.
    Whitehouse PJ, Martino AM, Antuono PG, Lowenstein PR, Coyle JT, Price DL, Kellar KJ.
    Brain Res; 1986 Apr 16; 371(1):146-51. PubMed ID: 3708340
    [Abstract] [Full Text] [Related]

  • 8. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.
    Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Honavar M, Dean A, Griffiths M, McKeith IG.
    Neuroreport; 1994 Mar 21; 5(7):747-9. PubMed ID: 8018843
    [Abstract] [Full Text] [Related]

  • 9. Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.
    Rylett RJ, Ball MJ, Colhoun EH.
    Brain Res; 1983 Dec 19; 289(1-2):169-75. PubMed ID: 6661641
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.
    Slotkin TA, Nemeroff CB, Bissette G, Seidler FJ.
    J Clin Invest; 1994 Aug 19; 94(2):696-702. PubMed ID: 8040324
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
    Wilcock GK, Esiri MM, Bowen DM, Smith CC.
    J Neurol Sci; 1982 Dec 19; 57(2-3):407-17. PubMed ID: 7161627
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.
    Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TJ.
    J Neurol Sci; 1981 Aug 19; 51(2):279-87. PubMed ID: 7276979
    [Abstract] [Full Text] [Related]

  • 16. Dementia without cholinergic deficit.
    Riekkinen PJ, Soininen H, Sirviö J, Reinikainen K, Helkala EL, Paljärvi L.
    Gerontology; 1987 Aug 19; 33(3-4):268-72. PubMed ID: 3653707
    [Abstract] [Full Text] [Related]

  • 17. The cholinergic system in old age and Alzheimer's disease.
    Perry EK.
    Age Ageing; 1980 Feb 19; 9(1):1-8. PubMed ID: 7361631
    [Abstract] [Full Text] [Related]

  • 18. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
    Palmer AM, Gershon S.
    FASEB J; 1990 Jul 19; 4(10):2745-52. PubMed ID: 2165009
    [Abstract] [Full Text] [Related]

  • 19. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL.
    Brain Res; 1987 Dec 08; 436(1):62-8. PubMed ID: 3690354
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.